首页> 外文期刊>Journal of laparoendoscopic and advanced surgical techniques, Part A >What Should be Done for Perforation of the Gallbladder During Laparoscopic Cholecystectomy: Prophylaxis or Treatment?
【24h】

What Should be Done for Perforation of the Gallbladder During Laparoscopic Cholecystectomy: Prophylaxis or Treatment?

机译:在腹腔镜胆囊切除术期间胆囊穿孔应该做些什么:预防或治疗?

获取原文
获取原文并翻译 | 示例
       

摘要

Background:Iatrogenic perforation of the gallbladder during laparoscopic cholecystectomy (LC) is one of the most common intraoperative complications, and there is no clear consensus among surgeons on this issue and there are studies reporting the antibiotic treatment. The aim of this study is to determine the effect of type and duration of antibiotic use on infective complications between iatrogenic perforations of the gallbladder during LC patients. Methods:Patients who developed iatrogenic perforation of gallbladder during LC were subdivided into three groups according to antibiotic treatment; single dose intravenous (i.v.) antibiotic group, prophylactic antibiotic + additional dose i.v. antibiotic group, and prophylaxis + additional dose i.v. antibiotic + oral antibiotic group. Results:A total of 577 patients who underwent LC were included in the study, and 114 patients (19.8%) had iatrogenic perforation of gallbladder. No statistically significant difference was found in wound infection and surgical site infection in all three groups (P > .05). Conclusions:We suggest that single dose antibiotic use is sufficient to prevent infectious complications in patients who had iatrogenic perforation of the gallbladder during LC. Adding intravenous and/or oral antibiotics does not contribute to prevention of infective complications in these patients.
机译:背景:腹腔镜胆囊切除术(LC)中医源性胆囊穿孔是最常见的术中并发症之一,外科医生对这一问题没有明确的共识,有研究报道了抗生素治疗。本研究的目的是确定LC患者使用抗生素的类型和持续时间对医源性胆囊穿孔感染并发症的影响。方法:将LC术中发生医源性胆囊穿孔的患者按抗生素治疗分为三组;单剂量静脉注射(i.v.)抗生素组、预防性抗生素+额外剂量i.v.抗生素组和预防性+额外剂量i.v.抗生素+口服抗生素组。结果:共有577名接受LC的患者被纳入研究,114名患者(19.8%)患有医源性胆囊穿孔。三组在伤口感染和手术部位感染方面均无统计学差异(P>0.05)。结论:对于LC期间医源性胆囊穿孔患者,单剂量抗生素使用足以预防感染性并发症。静脉注射和/或口服抗生素无助于预防这些患者的感染性并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号